Abstract Previous studies concerning the relevance of BDKRB2 gene polymorphisms revealed that the absence (-9 allele) of a nine-base-pair sequence in exon 1 of the BDKRB2 gene is correlated with higher skeletal muscle metabolic ef ciency, glucose uptake during exercise, and endurance athletic performance. The aim of the study was to investigate the association between the BDKRB2 -9/+9 polymorphism and elite athletic status in two cohorts of eastern European athletes. We examined the genotype distribution of the BDKRB2 9/+9 polymorphic site in a group of Polish athletes and con rmed the results obtained in a replication study of Russian athletes. Three hundred and two Polish athletes and 684 unrelated sedentary controls, as well as 822 Russian athletes and 507 unrelated sedentary volunteers, were recruited for this study. All samples were genotyped for the -9/+9 polymorphism within exon 1 of the BDKRB2 gene using polymerase chain reaction. Signi cance was assessed by chi square analysis with Bonferroni's correction for multiple testing. We found no statistical difference in the -9/+9 genotype and allele frequencies in two groups of athletes divided into four subgroups: endurance, sprint-endurance, sprint-strength, and strength athletes, compared with controls. There were no signi cant differences in allele frequencies (p = 0.477) and genotype distribution (p = 0.278) in the initial and replication studies. Thus, no association was
found between the BDKRB2 -9/+9 polymorphism and elite athletic status in two cohorts of eastern European athletes.
Angiotensin-converting enzyme (ACE) plays a signi cant role in circulatory homeostasis. It is a key component of the renin-angiotensin system (RAS), being responsible for the production of the vasoconstrictor angiotensin II. Moreover, it is a very important part of the kallikrein-kinin system (KKS), where ACE degrades a class of peptides known as kinins into inactive peptide fragments (Moreau et al. 2005; Jones and Woods 2003) . One of these is the vasodilator bradykinin, an ef cacious, short-lived effector of kinins, released from kininogens by proteolytic activity of kallikreins (Kammerer et al. 1995; Prado et al. 2002) . It participates in multiple physiological and pathological processes, including vascular dilation, increased vascular permeability, angioedema, smooth muscle contraction, pain, in ammation, neurotransmission, and cell proliferation (Kammerer et al. 1995; Braun et al. 1995) . Regoli and Barabé (1980) suggested that bradykinin acts via two plasma membrane receptors, the bradykinin 1 (BDKRB1) and 2 (BDKRB2) receptors. The majority of bradykinin's physiological effects are mediated by activation of cell-surface BDKRB2, which exhibits high af nity for kallidin (Lysbradykinin) and bradykinin (Kammerer et al. 1995) .
Activation of BDKRB2 results in increases in skeletal muscle glucose uptake during exercise, muscle blood ow, and endurance performance (Dietze et al. 1996; Henriksen et al. 1999) . Additionally, production of the vasodilator nitric oxide (NO) from arginine by the enzyme nitric oxide synthase (NOS) has been observed (Rett et al. 1990; Shen et al. 1995; May eld et al. 1996) . NO is one of the key substances that in uences blood pressure and basal vascular tone (Quyyumi et al. 1995; Kimura et al. 2003) .
BDKRB2 is encoded by a single copy of the BDKRB2 gene and is expressed in most human tissues Kammerer et al. 1995; Prado et al. 2002) . Ma et al. (1994) localized the BDKRB2 gene on chromosome 14q32. A three-exon structure for human BDKRB2 gene has been revealed, with the coding region in exons 2 and 3 (Kammerer et al. 1995) . The gene sequence is characterized by one polymorphism in the promoter region and three polymorphic sites located in each of the three exons (Kammerer et al. 1995; Braun et al. 1995) . The insertion/ deletion polymorphism (-9/+9, rs5810761) in exon 1 has been studied mainly in the context of associations between genotypes and physical performance, as well as hypertension and cardiovascular diseases (Hallberg et al. 2003; Fu et al. 2004; Saunders et al. 2006; Williams et al. 2004) . The -9 is associated with increased gene transcription and higher receptor mRNA expression compared with the +9 allele (Braun et al. 1996; Lung et al. 1997) .
Individuals with the +9 /+9 genotype were characterized by the lowest levels of BDKRB2 and showed the greatest increase in left ventricular mass, as well as less left ventricular mass regression, compared with other genotypes (Hallberg et al. 2003) . The presence of the BDKRB2 +9 allele was related to cardiovascular risk and increased blood pressure associated with hypertension (Dhamrait et al. 2003) . Increased activity of BDKRB2 observed for the -9 allele may be involved in determining endurance performance (Saunders et al. 2006) . These conclusions seem to be supported by Williams et al. (2004) , who demonstrated that the absence (-9), rather than the presence (+9), of a nine-basepair sequence in exon 1 of the BDKRB2 gene is strongly associated with higher skeletal muscle metabolic ef ciency, as well as endurance athletic performance. Additionally, Saunders et al. (2006) have con rmed that variants of the BDKRB2 gene that contribute to increased KKS activity are associated with endurance performance of South African triathletes. Previous studies have also shown that the +9/+9 genotype is strongly associated with left ventricular growth response in normotensive males undergoing physical training and change in left ventricular mass in response to antihypertensive treatment (Hallberg et al. 2003) . The aim of the study was to investigate the association between BDKRB2 -9/+9 polymorphism and elite athletic status in two cohorts of eastern European athletes. Therefore, we examined the genotype distribution of the BDKRB2 -9/+9 polymorphic site in a group of Polish athletes and con rmed the results obtained in a replication study of Russian athletes. The athletes were divided into four groups, covering a spectrum from the more endurance-oriented to the more strength-oriented (power-oriented) disciplines, according to the following values: relative aerobic/anaerobic energy system contribution, time of competitive exercise performance, and intensity of exertion in each sport.
Materials and Methods
The experimental procedures were conducted in accordance with the set of guiding principles for reporting the results of genetic association studies de ned by the Strengthening the Reporting of Genetic Association Studies (STREGA) Statement (Little et al. 2009 ).
Subjects and Controls.
The initial association study was done in a group of 302 Polish athletes of the highest nationally competitive standard (mean age, 27.8 ± 7.1 years; 221 males, 81 females). The athletes were prospectively strati ed into four groups according to the values of relative anaerobic/aerobic energy system contribution, time of competitive exercise performance, and intensity of exertion in each sport. The rst group, designated as endurance athletes, consisted of athletes (n = 26) with predominantly aerobic energy production (duration of exertion over 30 min, intensity of exertion moderate). This group included triathletes (n = 4), race walkers (n = 6), road cyclists (n = 14), and 15-50 km cross-country skiers (n = 2). The second group, designated as strength-endurance athletes (n = 66), comprised athletes whose sports utilize mixed anaerobic/aerobic energy production, with a duration of exertion ranging from 5 to 30 min and a moderate to high intensity of exertion. This group included rowers (n = 41), 3-to 10-km runners (n = 17), and 800-to 1,500-m swimmers (n = 8). The third group (sprint-strength athletes; n = 110) also included athletes with mixed energy production with shorter time of competitive exercise performance compared with the second group (1-5 min; in the case of combat sports, the duration of a single bout of competition was taken into account), while the intensity of exertion was higher and the balance between anaerobic/aerobic energy production was shifted toward the anaerobic system. This group comprised kayakers (n = 10), 800-to 1,500-m runners (n = 7), 200-to 400-m swimmers (n = 3), judokas (n = 13), wrestlers (n = 41), boxers (n = 19), and fencers (n = 17). The fourth group (strength athletes) consisted of athletes (n = 100) with predominantly anaerobic energy production (duration of exertion < 1 min, intensity of exertion submaximal to maximal): 100-to 400-m runners (n = 29), power lifters (n = 22), weight lifters (n = 20), throwers (n = 14), and jumpers (n = 15).
All Polish athletes recruited for this study were ranked in the top 10 nationally in their respective sports. The study population included 63 athletes classi ed as "top-elite" (gold medalists in the World and European Championships, World Cups, or Olympic Games) and 149 athletes classi ed as "elite" (silver or bronze medalists in the World and European Championships, World Cups, or Olympic Games). The others (n = 90) were classi ed as "subelite" (participants in international competitions). Various methods were used to obtain the samples, including targeting national teams and providing information to national coaching staff and athletes attending training camps.
Control samples were prepared from 684 unrelated, sedentary volunteers (students of the University of Szczecin, 19-23 years of age; 153 females and 531 males; mean age, 24.3 ± 0.2 years). All athletes and controls were Caucasian to reduce the possibility of racial gene skew and to overcome any potential problems due to population strati cation. The procedures followed in the study were approved by the Pomeranian Medical University Ethics Committee. All participants gave informed consent to genotyping with the understanding that it was anonymous and that obtained results would have con dential status.
The replication study was done in 822 Russian athletes of a nationally competitive standard (286 females and 536 males; mean age, 25.3 ± 0.2 years). The athletes were divided into four groups according to the parameters established for the initial association study. The group of endurance athletes (n = 100) included biathletes (n = 39), cross-country skiers (n = 44), and long-distance (5-25 km) swimmers (n = 17). The group of strength-endurance athletes (n = 95) consisted of rowers (n = 76), 3-to 10-km runners (n = 5), 800-to 1,500-m swimmers (n = 9), and 5-to 10-km skaters (n = 5). The group of sprint-strength athletes (n = 530) comprised kayakers (n = 34), 800-to 1,500-m runners (n = 3), 200-to 400-m swimmers (n = 37), boxers (n = 25), wrestlers (n = 112), alpine skiers (n = 19), short trackers (n = 22), 1.5-to 3-km speed skaters (n = 7), fencers (n = 60), football players (n = 82), ice hockey players (n = 70), and artistic gymnasts (n = 59). The strength athletes group (n = 97) consisted of 100-to 400-m runners (n = 10), 500-to 1,000-m skaters (n = 13), 50-to 100-m swimmers (n = 28), weight lifters (n = 34), throwers (n = 5), and jumpers (n = 7). There were 364 athletes classi ed as "elite" (ranked in the top 10 nationally), of whom 105 were "top-elite" athletes (award winners of the World and European Championships, World Cups, or Olympic Games). There were 272 athletes classi ed as "subelite" (participants in international competitions). The others (n = 186) were classi ed as "nonelite" athletes, being regional competitors with no less than four years' experience participating in their sports.
Controls were 507 healthy, unrelated citizens (354 females and 153 males; mean age, 22.1 ± 0.2 years) of St. Petersburg and Surgut without any competitive sport experience. The geographic ancestry of the athletes and control groups was self-reported. The athletes and control groups were all Caucasian (predominantly Russians). The University of St. Petersburg Ethics Committee approved the study, and written informed consent was obtained from each participant.
Genetic Analyses. In the Polish study, genomic DNA was extracted from the buccal cells using a GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Germany) according to the manufacturer's instructions.
In the Russian study, genotyping was performed on DNA samples obtained from epithelial mouth cells by alkaline extraction, or with a DNK-sorb-A sorbent kit (Central Research Institute of Epidemiology, Russia) according to the manufacturer's instructions, depending on the method of sample collection (buccal swab or scrape).
All samples were genotyped for the -9/+9 polymorphism within exon 1 of the BDKRB2 gene using polymerase chain reaction (PCR). The 100-and/or 91-base-pair fragments of the gene were ampli ed by PCR using the forward primer 5 -TCTGGCTTCTGGGCTCCGAG-3 and the reverse primer 5 -AGCG-GCATGGGCACTTCAGT-3 as recommended by Williams et al. (2004) . The reaction was carried out in a total volume of 10 l containing 1.5 mM MgCl 2 , 0.75 nM each dNTP (Novazym, Poland, or Sibenzyme, Russia), 4 pM each primer (Genomed, Poland, or Lytech, Russia), 0.5 U Taq DNA polymerase (Sigma, Germany, or Sibenzyme, Russia), and 1 l (30-50 ng) genomic DNA. After the rst 5-min step at 94°C, 35 cycles of ampli cation were performed by using denaturation at 94°C for 30 s, annealing at 62°C for 1 min, and elongation at 72°C for 30 s, followed by a nal cycle at 72°C for 10 min. The ampli ed PCR fragments were separated by 7.5% polyacrylamide gel electrophoresis, stained with ethidium bromide, and visualized in ultraviolet light.
Statistical Analysis.
The Statistica statistical package, version 7.0 (StatSoft, Inc., USA), was used to perform all statistical evaluations. A chi square test was used to compare the BDKRB2 -9/+9 alleles and genotype frequencies between athletes and control subjects. Bonferroni's correction for multiple testing was performed by dividing the p-value (0.05) with the number of tests.
Results
The results of the genotype distribution of the BDKRB2 -9/+9 polymorphism in Polish and Russian athletes and controls met Hardy-Weinberg expectations (p > 0.05 in all groups tested separately). BDKRB2 genotype distribution results of the Polish control group (+9/+9, 28.8%; +9/-9, 50.7%; -9/-9, 20.5%) and Russian control group (+9/+9, 29.4%; +9/-9, 49.5%; -9/-9, 21.1%) were similar to those reported in previous studies on Caucasian populations (Braun et al. 1996; Brull et al. 2001; Lung et al. 1997; Williams et al. 2004 ). There were no signi cant differences in the BDKRB2 genotype and allele frequencies between males and females among both athletes and controls of both ethnic groups (data not shown). The initial association study done in the Polish athlete group (Table 1) revealed that the genotype distributions (p = 0.739) and allele frequencies (47.02 % vs. 45.83 %; p = 0.626) of the BDKRB2 -9/+9 polymorphism did not differ between athletes and sedentary controls. Any observed differences were not statistically signi cant when considering the frequency of the -9 allele in the four groups of athletes separately: endurance athletes (42.31%; p = 0.616), strength-endurance athletes (45.45%; p = 0.933), sprint-strength athletes (47.73%; p = 0.601), and strength athletes (48.50%; p = 0.479).
Compared with controls, statistically signi cant differences in genotype distribution were not observed in the whole cohort of Polish athletes (+9/+9, 26.50%; +9/-9, 53.00%; -9/-9, 20.50%; p = 0.626) or in each group separately: groups of endurance athletes (p = 0.812), sprint-endurance athletes (p = 0.940), sprint-strength athletes (p = 0.763), or strength athletes (p = 0.442).
The results were obtained in the replication study (Table 2) . Compared with controls, the -9 allele frequencies among all Russian athletes did not reach statistical signi cance (46.90% vs. 45.86%; p = 0.321). The differences in the -9 allele frequencies were also not statistically signi cant in the endurance athletes (45.50%; p = 0.938), strength-endurance athletes (45.80%; p = 1.000), sprint-strength athletes (46.89%; p = 0.670), or strength athletes (49.48%; p = 0.353).
The genotype distributions of the BDKRB2 +9/-9 polymorphism in all Russian athletes (+9/+9, 26.4%; +9/-9, 53.4%; -9/-9, 20.2%; p = 0.404) were not different from those of controls (+9/+9, 29.4%; +9/-9, 49.5%; -9/-9, 21.1%), nor were those of endurance athletes (p = 0.804), sprint-endurance athletes (p = 0.932), sprint-strength athletes (p = 0.257), or strength athletes (p = 0.648).
Combining the results of the initial and replication studies (Table 3) , signi cant differences in the frequency of the -9 allele were not found in the whole cohort of Polish and Russian athletes compared with controls (46.93% vs. 45.84%; p = 0.477). The same situation was observed when comparing the differences of genotype distribution between all Polish and Russian athletes and controls (+9/+9, 26.4%; +9/-9, 53.3%; -9/-9, 20.3% vs. +9/+9, 29.1%; +9/-9, 50.2%; -9/-9, 20.7%; p = 0.278). Within the four groups of athletes, the -9 allele frequency and the genotype distribution of the BDKRB2 -9/+9 did not statistically differ from controls.
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athletic status, we investigated the genotype distribution and allele frequency in three subgroups of athletes: top elite, elite, and subelite (Table 4 ). There were no signi cant differences in the BDKRB2 genotype or in allele frequencies between each Polish and Russian subgroup, or among controls of either ethnic group.
Discussion
The present report is a genetic case-control association study in which we examined the genotype distribution of the BDKRB2 -9/+9 polymorphism in a group of Polish athletes and con rmed the results in a replication study of Russian athletes. Our main ndings were that (1) neither the BDKRB2 -9 and +9 alleles nor the BDKRB2 -9/+9 genotypes were signi cantly more frequent among four groups of Polish and Russian athletes of different metabolic demands than in controls and (2) no association between athletes of different competitive levels was observed when genotype and allele frequencies were compared among the top-elite, elite, and subelite athletes and controls in initial and replication studies. Reports regarding the connection between the BDKRB2 +9/-9 polymorphism and sport performance level are still limited. Prior to this study, only a few reports concerned the role of the BDKRB2 gene for sport performance. The literature data showed that the -9 allele of a BDKRB2 gene is linked with increased gene transcription and higher receptor mRNA expression (Braun et al. 1996; Lung et al. 1997) . Williams et al. (2004) suggested that the BDKRB2 -9 allele is associated with higher skeletal muscle metabolic ef ciency. What is more, the analysis revealed a linear trend of increasing -9 allele frequency with distance run in 81 Olympic standard track athletes, which seems to prove the importance of the BDKRB2 -9 allele for endurance athletic performance.
This nding seems to be supported by Saunders et al. (2006) , who found statistically signi cant differences in -9/+9 distribution between 443 male Caucasian triathletes and 203 healthy Caucasian male controls. In this case, the -9/-9 BDKRB2 genotype was overrepresented in the whole cohort of athletes compared with controls. However, when divided into tertiles according to their nishing times, the -9/-9 genotype was overrepresented only in the fastest tertile. There were no signi cant differences in the frequencies of the allele distributions between any of the triathletes and controls.
A report concerning the role of the BDKRB2 gene in sport was also published by Tsianos et al. (2010) . They investigated the genotype distribution and allele frequency of eight chosen genetic polymorphisms in 438 athletes participating in 2007 and 2008 annual Olympus Marathon, including C58T BDKRB2 polymorphism rs1799722. Although they evaluated only single-nucleotide polymorphisms, their ndings seem to support the reports of Williams et al. (2004) and Saunders et al. (2006) . They found results consistent with previous studies: the high-transcription allele was overrepresented in this group of endurance athletes, and even more so among those who were habitual runners.
Another aspect of the +9/-9 BDKRB2 polymorphism that warrants further (Murphey et al. 2000) . Knowing this fact, Williams et al. (2004) investigated the role of the ACE and BDKRB2 genotype combination for predisposition to sport performance. Their ACE and BDKRB2 analysis demonstrated a signi cant relationship with distance run ( 5,000 vs. 5,000 m), both overall and for Caucasians only, with a greater proportion of "low kinin receptor activity" (ACE D allele, BDKRB2 +9 allele) in events <5,000 m and, conversely, a greater proportion of "high kinin receptor activity" haplotypes (ACE I allele, BDKRB2 -9 allele) competing in events >5,000 m (Williams et al. 2004) .
Another example concerned the correlation of the BDKRB2 gene with the NOS3 gene. Saunders et al. (2006) pointed out that the effect of the genotype NOS3 GG, advantageous for endurance performance, appeared only in connection with BDKRB2 genotype (-9/-9). In other combinations of genotypes of both genes (NOS3 and BDKRB2), the genotype GG did not show any positive correlation with an increase in sport endurance.
Contrary to these ndings, Eynon et al. (2001) showed no association between the C825T polymorphism in the gene GNB3 coding for the guanine nucleotide binding protein -polypeptide 3 and BDKRB2 -9/+9 polymorphic site, despite the fact that the C825T polymorphism within the GNB3 gene was itself previously correlated with elite athletic performance (Eynon et al. 2009 ).
Our results and the results of Eynon et al. (2001) are in opposition to the observations of Williams et al. (2004) and Saunders et al. (2006) . In our study, we did not nd any statistical difference in +9/-9 genotype and allele frequencies in any of four investigated athletes groups (i.e., endurance athletes, sprint-endurance athletes, sprint-strength athletes and strength athletes) compared with sedentary controls. Notably, we obtained the same results in both the initial study with Polish athletes and the replication study with Russian athletes (1,124 athletes total). Eynon et al. (2001) found that allele frequencies and genotype distribution were similar in both athlete and control groups. They also found no statistical differences between the subgroups of elite and national-level athletes.
The discrepancy between results described above may be due to differences in sample size, study designs, and elite athletes' phenotype classi cation. The positive ndings have emerged from relatively smaller cohorts (Saunders et al. 2006) or from studies of a different study design (Williams et al. 2004 ). In our study, we were able to recruit large enough samples of elite athletes (>1,100 athletes) in an attempt to overcome the sample size limitation, making our study unique. Moreover, all participants were of similar ethnic and geographic backgrounds, as evidenced by similar minor allele frequencies. In our opinion this enabled us to reach suf cient statistical power and obtain reliable conclusions. The same methodological approach was applied in our previous work (Eynon et al. 2012 ), and our results should be considered valid, since all STREGA criteria were met (Little et al. 2009 ): all athletes represented an elite level of competition; participants within each cohort were ethnically matched; genotyping was accurate and unbiased; and genotype distributions were in Hardy-Weinberg equilibrium in both athlete groups and control groups of the two analyzed eastern European cohorts.
However, our study is not without limitations. Elite athletic status is a complex polygenic trait involving complex gene-gene interactions, as well as geneenvironment interactions (Lucía et al. 2010) . Thus, the numerous polymorphic sites in candidate genes should be analyzed to explain individual variation of elite athletic status. It must be kept in mind that even if the -9/+9 BDKRB2 polymorphism is not correlated with a predisposition to athletic performance, other polymorphisms in the BDKRB2 gene could hypothetically in uence elite athlete status.
Perspectives
Athletic ability is a trait that involves genes that are in uenced by environmental factors. Genetic components include numerous candidate genes whose natural allelic variants occur in the general population. Identifying these polymorphisms that could have an impact on athletic performance is a matter of investigation worldwide. However, one of the main de ciencies of association studies is an inadequate number of subjects and/or a lack of replication studies. In this study, we demonstrate that there is no signi cant association between the +9/-9 polymorphic site in the BDKRB2 candidate gene and athletic performance in two independent studies of large cohorts of Polish and Russian athletes. Our results are contrary to the hypothesis that the BDKRB2 -9/+9 polymorphism is associated with athletic ability. Our nding does not mean that other polymorphisms in the BDKRB2 gene do not have any bene cial effect on performance parameters. There might also be possible interactions with other genetic factors, because sports-related phenotypes are highly polygenic, and more than 79 polymorphisms are suggested to in uence the athletes' results (Ahmetov and Fedotovskaya 2012; Williams and Folland 2008) . In our opinion, there is a need for further investigation in the eld using independent cohorts of athletes of the same, as well as different ethnic backgrounds, to replicate the obtained results and thus clarify the potential role of polymorphic variants of candidate genes in determining sport performance abilities.
